Patents

Search tools Text Classification Chemistry Measure Numbers Full documents Title Abstract Claims All Any Exact Not Add AND condition These CPCs and their children These exact CPCs Add AND condition
Exact Exact Batch Similar Substructure Substructure (SMARTS) Full documents Claims only Add AND condition Add AND condition
Application Numbers Publication Numbers Either Add AND condition

Pharmaceutical compositions

Classifications

A61K9/2095 Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
View 3 more classifications

Landscapes

Health & Medical Sciences Veterinary Medicine
Show more

ZA967032B

South Africa

Find Prior Art Similar
Other languages
English
Inventor
Edward Stewart Johnson
Anthony Clarke
Richard David Green
Worldwide applications
1995 GB 1996 AU CZ UA EE CA BR SK WO PT MX HU AT NZ DK RU RO EP DE PL JP ES ZA 1998 BG NO 2000 US GR
Application ZA967032A events
1996-08-19
Application filed by Scherer Ltd R P
1997-03-04
Publication of ZA967032B
Info
Patent citations (30)
Cited by (156)
Similar documents
Priority and Related Applications
External links
Espacenet
Global Dossier
Discuss

Patent Citations (30)

Publication number Priority date Publication date Assignee Title
Family To Family Citations
IE45770B1 * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
DE3216869A1 * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
IT1200609B * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano
US5288497A * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
HU193780B * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof
JPS63501717A * 1985-10-29 1988-07-14 ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド 抗原誘発性アレルギ−反応を阻止するための方法および組成物
NZ220599A * 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa
DE3631088A1 * 1986-09-12 1988-06-23 Ferring Arzneimittel Gmbh Verwendung von opiat-antagonisten zur diagnose und therapie von hypothalamischen funktionsstoerungen
US4855326A * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
GB8712073D0 * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
US5234957A * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3831088A1 * 1988-09-13 1990-03-15 Jochen Gasda Preisauszeichnungseinrichtung und verfahren zum aufbringen von preisauszeichnungen auf einen preisauszeichnungstraeger
US5073374A * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5079018A * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
DK0494972T3 1989-10-02 1997-05-12 Cima Labs Inc Brusedosisform samt fremgangsmåde til administration heraf
GB9015095D0 * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
GB9216297D0 * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
PL171695B1 * 1991-11-04 1997-06-30 Fuisz Technologies Ltd Chewing gum
HU219349B * 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
JP3069458B2 * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
HUT75616A * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5298261A 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
CA2095776C * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
IL108366A * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
ES2194867T3 * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
DE4320678C2 1993-06-22 1996-04-11 Branko Dipl Ing Klasnic Vorrichtung zum Entfernen von Rechengut aus einer mit einer verunreinigten Flüssigkeit durchströmten Zulaufrinne, insbesondere von Kläranlagen
GB9421836D0 * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
GB9517062D0 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
* Cited by examiner, † Cited by third party

Cited By (156)

Publication number Priority date Publication date Assignee Title
Family To Family Citations
US6121276A * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US5888534A * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US20040023948A1 * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
ATE333279T1 * 1997-05-19 2006-08-15 Zonagen Inc Kombinationstherapie zur modulation der humanen sexualreaktion
JP2002507982A 1997-07-01 2002-03-12 イムプリコ ベスローテン フェンノートシャップ 迅速な放出性の組成物
US20030091629A1 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
GB9904911D0 * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
GB9908014D0 * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
PL366204A1 * 1999-12-30 2005-01-24 Tap Holdings, Inc. Oral mucosal dosage forms of apomorphine
WO2002011727A1 * 2000-08-08 2002-02-14 Teva Pharmaceutical Industries Ltd. Stable pergolide mesylate and process for making same
JP2004506621A * 2000-08-16 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 嗜癖障害治療用の化合物
SE0102036D0 * 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
SE0002934D0 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
CA2426682C * 2000-10-16 2010-02-16 Daiichi Pharmaceutical Co., Ltd. Intraoral rapid-disintegrating medicinal compositions and production process thereof
DE10107659B4 * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US20030068356A1 * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
FR2834894B1 * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
US7217696B2 2002-02-28 2007-05-15 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
WO2003079980A2 * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
CA2479372A1 * 2002-03-19 2003-10-02 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
PT2425824T * 2002-04-05 2017-08-23 Mundipharma Farmacêutica Lda Preparação farmacêutica contendo oxicodona e naloxona
WO2003086475A1 * 2002-04-12 2003-10-23 A & D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
WO2003092591A2 * 2002-04-30 2003-11-13 Npd Llc Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
US20050153928A1 * 2002-05-07 2005-07-14 Holick Michael F. Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
WO2004000223A2 * 2002-06-20 2003-12-31 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
US20050215487A1 * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
GB0217056D0 * 2002-07-23 2002-08-28 Ass Octel Use
US8821915B2 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
GB0226076D0 * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
US20040156894A1 * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
RU2224518C1 * 2003-02-10 2004-02-27 Дулькис Мария Дмитриевна Жидкая лекарственная форма налтрексона
MXPA05011557A 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
US7862833B2 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
AU2004311880B2 * 2003-12-31 2010-08-05 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A2 * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US7576073B2 2004-05-28 2009-08-18 UNIVERSITé LAVAL Combined therapy for the treatment of parkinson's disease
US7972621B2 * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
EP1765287A2 * 2004-06-17 2007-03-28 Merz Pharma GmbH & Co. KGaA Immediate release formulations of memantine oral dosage forms
CA2628298A1 * 2004-11-03 2006-05-11 Clera Inc. Method to detect dopamine receptors in the functional d2high state
CA2599384A1 * 2005-03-28 2006-10-05 Orexo Ab New pharmaceutical compositions useful in the treatment of parkinson's disease
GB0509317D0 * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
US20070128285A1 * 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration
US20070020186A1 * 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
US20070105867A1 * 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
CN101370488B 2005-11-22 2012-07-18 奥雷西根治疗公司 增加胰岛素敏感性的组合物
US8916195B2 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
US20080039433A1 * 2006-06-15 2008-02-14 Smith Alexander D Stabilized Tetracycline Compositions
DE102006027793A1 * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
US20080014228A1 * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
EP1897543A1 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
KR20180066272A 2006-11-09 2018-06-18 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
US20080311162A1 * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20100035886A1 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
US8741918B2 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20110111014A1 * 2007-06-26 2011-05-12 Parkinson's Institute Methods and compositions for treatment of neurological disorders
US20090004248A1 * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090004231A1 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
EP2303025A4 2008-05-30 2012-07-04 Orexigen Therapeutics Inc METHOD FOR TREATING DIGITAL FAT SWITCHES
WO2010019856A1 * 2008-08-15 2010-02-18 The Mclean Hospital Corporation Methods and kits for treatings stroke and other neurological conditions
DE102009036285A1 * 2008-10-13 2010-04-15 Illinois Tool Works Inc., Glenview Verfahren zur Herstellung eines Bohrers, insbesondere eines Gesteinsbohrers
US20100116281A1 2008-11-07 2010-05-13 Jerry Wayne Marshall Tobacco products and processes
US9352025B2 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
CA2765291C 2009-06-12 2016-03-08 Adagio Pharmaceuticals Ltd. Sublingual apomorphine
US8545879B2 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
PT2482822T * 2009-10-01 2018-10-04 Adare Pharmaceuticals Inc Composições de corticosteroide administradas oralmente
US12186426B2 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CA2777218C 2009-10-30 2016-09-27 Ix Biopharma Pte Ltd Fast dissolving solid dosage form
BR112012016783A2 2010-01-11 2015-09-01 Orexigen Therapeutics Inc "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
US9675102B2 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
BR112013009255B1 * 2010-10-08 2021-02-23 R.P. Scherer Technologies, Llc composição sólida de vacina oral de dissolução rápida
WO2012083269A1 2010-12-16 2012-06-21 Cynapsus Therapeutics, Inc. Sublingual films
US10881132B2 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
PE20150358A1 2012-06-06 2015-04-06 Orexigen Therapeutics Inc Metodos para el tratamiento del sobrepeso y de la obesidad
JP6407953B2 2013-03-15 2018-10-17 アール・ジエイ・レイノルズ・タバコ・カンパニー 材料のシートから形成される加熱素子、アトマイザーの生産用のインプット及び方法、エアロゾル送達装置用のカートリッジ、並びに喫煙具用のカートリッジを組み立てるための方法
WO2015034678A2 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
KR20160108828A * 2013-11-11 2016-09-20 임팩스 라보라토리즈, 인코포레이티드 신속하게 붕괴되는 제형 및 사용 방법
US8969371B1 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations
ES3015535T3 2015-04-21 2025-05-06 Sumitomo Pharma America Inc Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US10611505B2 2015-05-04 2020-04-07 Rai Strategic Holdings, Inc. Dispensing machine for aerosol precursor
US10238145B2 2015-05-19 2019-03-26 Rai Strategic Holdings, Inc. Assembly substation for assembling a cartridge for a smoking article
US20170112194A1 2015-10-21 2017-04-27 Rai Strategic Holdings, Inc. Rechargeable lithium-ion capacitor for an aerosol delivery device
US10820630B2 2015-11-06 2020-11-03 Rai Strategic Holdings, Inc. Aerosol delivery device including a wirelessly-heated atomizer and related method
US10104912B2 2016-01-20 2018-10-23 Rai Strategic Holdings, Inc. Control for an induction-based aerosol delivery device
US11207478B2 2016-03-25 2021-12-28 Rai Strategic Holdings, Inc. Aerosol production assembly including surface with micro-pattern
US10334880B2 2016-03-25 2019-07-02 Rai Strategic Holdings, Inc. Aerosol delivery device including connector comprising extension and receptacle
US10405579B2 2016-04-29 2019-09-10 Rai Strategic Holdings, Inc. Methods for assembling a cartridge for an aerosol delivery device, and associated systems and apparatuses
US11019847B2 2016-07-28 2021-06-01 Rai Strategic Holdings, Inc. Aerosol delivery devices including a selector and related methods
TWI728172B 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10477896B2 2016-10-12 2019-11-19 Rai Strategic Holdings, Inc. Photodetector for measuring aerosol precursor composition in an aerosol delivery device
US20180132528A1 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Photoelectric proximity sensor for gesture-based control of an aerosol delivery device
US20180132529A1 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Aerosol delivery device with integrated wireless connectivity for temperature monitoring
US10524508B2 2016-11-15 2020-01-07 Rai Strategic Holdings, Inc. Induction-based aerosol delivery device
US10537137B2 2016-11-22 2020-01-21 Rai Strategic Holdings, Inc. Rechargeable lithium-ion battery for an aerosol delivery device
EP3547858B1 2016-12-01 2025-04-30 RAI Strategic Holdings, Inc. Rechargeable lithium-ion capacitor for an aerosol delivery device
EP3549235B1 2016-12-02 2021-05-05 RAI Strategic Holdings, Inc. Induction charging for an aerosol delivery device
US11013266B2 2016-12-09 2021-05-25 Rai Strategic Holdings, Inc. Aerosol delivery device sensory system including an infrared sensor and related method
US10517326B2 2017-01-27 2019-12-31 Rai Strategic Holdings, Inc. Secondary battery for an aerosol delivery device
US10759554B2 2017-02-02 2020-09-01 Rai Strategic Holdings, Inc. Dispenser unit for aerosol precursor
US10827783B2 2017-02-27 2020-11-10 Rai Strategic Holdings, Inc. Digital compass for an aerosol delivery device
US10314340B2 2017-04-21 2019-06-11 Rai Strategic Holdings, Inc. Refillable aerosol delivery device and related method
US11297876B2 2017-05-17 2022-04-12 Rai Strategic Holdings, Inc. Aerosol delivery device
US10517330B2 2017-05-23 2019-12-31 RAI Stategic Holdings, Inc. Heart rate monitor for an aerosol delivery device
US11337456B2 2017-07-17 2022-05-24 Rai Strategic Holdings, Inc. Video analytics camera system for an aerosol delivery device
US10349674B2 2017-07-17 2019-07-16 Rai Strategic Holdings, Inc. No-heat, no-burn smoking article
US10791761B2 2017-08-17 2020-10-06 Rai Strategic Holdings, Inc. Microtextured liquid transport element for aerosol delivery device
US10505383B2 2017-09-19 2019-12-10 Rai Strategic Holdings, Inc. Intelligent charger for an aerosol delivery device
US11039645B2 2017-09-19 2021-06-22 Rai Strategic Holdings, Inc. Differential pressure sensor for an aerosol delivery device
US10660370B2 2017-10-12 2020-05-26 Rai Strategic Holdings, Inc. Aerosol delivery device including a control body, an atomizer body, and a cartridge and related methods
US12114688B2 2017-10-24 2024-10-15 Rai Strategic Holdings, Inc. Method for formulating aerosol precursor for aerosol delivery device
US10806181B2 2017-12-08 2020-10-20 Rai Strategic Holdings, Inc. Quasi-resonant flyback converter for an induction-based aerosol delivery device
US10555558B2 2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10813385B2 2018-03-09 2020-10-27 Rai Strategic Holdings, Inc. Buck regulator with operational amplifier feedback for an aerosol delivery device
US11206864B2 2018-03-26 2021-12-28 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10959459B2 2018-05-16 2021-03-30 Rai Strategic Holdings, Inc. Voltage regulator for an aerosol delivery device
US11094993B2 2018-08-10 2021-08-17 Rai Strategic Holdings, Inc. Charge circuitry for an aerosol delivery device
US10939707B2 2018-08-23 2021-03-09 Rai Strategic Holdings, Inc. Aerosol delivery device with segmented electrical heater
US11592793B2 2018-11-19 2023-02-28 Rai Strategic Holdings, Inc. Power control for an aerosol delivery device
US11614720B2 2018-11-19 2023-03-28 Rai Strategic Holdings, Inc. Temperature control in an aerosol delivery device
US11753750B2 2018-11-20 2023-09-12 R.J. Reynolds Tobacco Company Conductive aerosol generating composite substrate for aerosol source member
US11547816B2 2018-11-28 2023-01-10 Rai Strategic Holdings, Inc. Micropump for an aerosol delivery device
US11096419B2 2019-01-29 2021-08-24 Rai Strategic Holdings, Inc. Air pressure sensor for an aerosol delivery device
US20200245696A1 2019-02-06 2020-08-06 Rai Strategic Holdings, Inc. Buck-boost regulator circuit for an aerosol delivery device
US11456480B2 2019-02-07 2022-09-27 Rai Strategic Holdings, Inc. Non-inverting amplifier circuit for an aerosol delivery device
US12140978B2 2019-03-01 2024-11-12 Rai Strategic Holdings, Inc. Temperature control circuitry for an aerosol delivery device
US11324249B2 2019-03-06 2022-05-10 R.J. Reynolds Tobacco Company Aerosol delivery device with nanocellulose substrate
CA3132789A1 2019-03-08 2020-09-17 Rai Strategic Holdings, Inc. Method for hydrolysis of lactic acid for aerosol delivery device
US11200770B2 2019-04-02 2021-12-14 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through visual communication
US11676438B2 2019-04-02 2023-06-13 Rai Strategic Holdings, Inc. Authentication and age verification for an aerosol delivery device
US11935350B2 2019-04-02 2024-03-19 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through speaker communication
US11783395B2 2019-04-24 2023-10-10 Rai Strategic Holdings, Inc. Decentralized identity storage for tobacco products
US11690405B2 2019-04-25 2023-07-04 Rai Strategic Holdings, Inc. Artificial intelligence in an aerosol delivery device
US12232543B2 2019-05-17 2025-02-25 Rai Strategic Holdings, Inc. Age verification with registered cartridges for an aerosol delivery device
US12022859B2 2019-07-18 2024-07-02 R.J. Reynolds Tobacco Company Thermal energy absorbers for tobacco heating products
KR102810768B1 2019-08-29 2025-05-21 레이 스트라티직 홀딩스, 인크. 이중 챔버 에어로졸 디스펜서
GB201912686D0 2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition
US11785991B2 2019-10-04 2023-10-17 Rai Strategic Holdings, Inc. Use of infrared temperature detection in an aerosol delivery device
US11470689B2 2019-10-25 2022-10-11 Rai Strategic Holdings, Inc. Soft switching in an aerosol delivery device
EP4061164B1 2019-11-18 2025-06-25 RAI Strategic Holdings, Inc. Security tag
EP4084641A1 2019-12-30 2022-11-09 RAI Strategic Holdings, Inc. A heart rate monitor for an aerosol delivery device
AR121656A1 2020-03-26 2022-06-29 Rai Strategic Holdings Inc Métodos, aparatos y sistemas para activar un dispositivo antes de accionar el dispositivo
US20210321655A1 2020-04-16 2021-10-21 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate
US20210321674A1 2020-04-21 2021-10-21 Rai Strategic Holdings, Inc. Pressure-sensing user interface for an aerosol delivery device
US11839240B2 2020-04-29 2023-12-12 Rai Strategic Holdings, Inc. Piezo sensor for a power source
WO2021250516A1 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11771132B2 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
US11771136B2 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
US11672761B2 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US20220183389A1 2020-12-11 2022-06-16 Rai Strategic Holdings, Inc. Sleeve for smoking article
CA3216322A1 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition
US20240374524A1 2023-05-11 2024-11-14 Catalent U.K. Swindon Zydis Limited Increasing permeation for pre-gastric absorption of active pharmaceutical ingredients
WO2025064381A1 * 2023-09-18 2025-03-27 Phathom Pharmaceuticals Inc. Method for preparing vonoprazan with reduced nitrosamine
EP4585059A1 2024-01-12 2025-07-16 Nicoventures Trading Limited Effervescent pouched product
* Cited by examiner, † Cited by third party, ‡ Family to family citation

Similar Documents

Publication Publication Date Title
ZA967032B 1997-03-04 Pharmaceutical compositions
WO2001085257A3 2002-06-13 Opioid antagonist compositions and dosage forms
YU35893A 1997-03-07 Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
HUP0203451A2 2003-02-28 Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
HUP0003405A2 2001-02-28 Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
RU99117926A 2001-06-10 Лекарственные формы и способ лечения расстройства мужской эректильной функции
HUP0001894A2 2001-04-28 N-Piperidino-3-pirazolkarboxamid-származékot, sóját vagy szolvátját tartalmazó orálisan adagolható gyógyszerkészítmény
AU3357800A 2000-08-25 Method of preparing alkylated salicylamides
EE9900288A 2000-02-15 Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
KR930007439A 1993-05-20 방출 조절형 제약 조성물
NO20000466D0 2000-01-28 Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
MXPA03000548A 2004-04-05 Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
CA2378613A1 2001-01-11 Selective iglur5 receptor antagonists for the treatment of migraine
EP1064966A3 2003-01-08 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
ZA933178B 1994-01-10 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration
WO2006053089A3 2006-08-24 Methods and formulations for making pharmaceutical compositions containing bupropion
PT1121109E 2006-09-29 Formulacao bifasica contendo tramadol
GEP20043377B 2004-04-13 Pharmaceutical Complex
PT1546067E 2007-06-27 Composição fumígena
MXPA05008921A 2005-10-05 Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
EP1064948A3 2003-01-08 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
US5776987A 1998-07-07 Pharmaceutical suspension formulation
TW200621314A 2006-07-01 Methods and formulations for making pharmaceutical compositions containing bupropion
MY102368A 1992-06-17 Solid sustained-release composition

Priority And Related Applications

Applications Claiming Priority (1)

Application Filing date Title
GBGB9517062.7A 1995-08-18 Pharmaceutical compositions

Concepts

machine-extracted
Download Filter table
Name Image Sections Count Query match
pharmaceutical composition title,abstract 2 0.000
active ingredient abstract 3 0.000
mixture abstract 3 0.000
solid abstract 2 0.000
solvent abstract 2 0.000
Gelatin abstract 1 0.000
anti-emetic effect abstract 1 0.000
antiemetic agent abstract 1 0.000
chemical substances by application abstract 1 0.000
dopamine receptor stimulating agent abstract 1 0.000
dosage form abstract 1 0.000
gelatin abstract 1 0.000
gelatin abstract 1 0.000
gelatine abstract 1 0.000
gelatine desserts abstract 1 0.000
matrix material abstract 1 0.000
mouth abstract 1 0.000
opiate antagonist abstract 1 0.000
water abstract 1 0.000
Show all concepts from the description section
Data provided by IFI CLAIMS Patent Services